Home > News By Company > RNCOS
RNCOS - Russian Pharmaceutical Industry Set for Blistering Growth
Increasing healthcare expenditure and active government support will propel the Russian pharmaceutical industry to reach new heights in coming years.
(EMAILWIRE.COM, March 03, 2010 ) New Delhi, India - The Russian pharmaceutical industry has been witnessing strong growth over the last few years and the present trend will continue in future as well. Our new research report “Russian Pharma Sector Forecast to 2013” has also projected that the pharmaceutical industry will grow at a CAGR of around 26% during 2010-2013 on account of rising concerns of inflation with respect to drugs.
Besides high prices of drugs, the Russian pharmaceutical industry will benefit from the dynamic government support and increasing private investments. Several other factors such as growing healthcare spending and obligatory and voluntary insurance schemes have boosted the intake of high-priced drugs in the country. Infectious diseases like HIV/AIDS are on the rise and Russia is transforming into a more conducive environment for clinical trials, which will further pave the way for the growth of pharmaceutical industry in the country.
Our research indicates that the Russian pharmaceutical market has immense growth potential and is in the initial stages of development. The country is highly dependent on imported drugs, giving room to private players to set up their own manufacturing capacities. This will boost the commercial drugs segment to occupy the largest market share by 2013.
Although the future prospects of commercial drugs segment seem optimistic and encouraging, there are still several factors that may restraint the growth of pharmaceutical market in Russia. Our research report throws light on these restraints to help clients comprehend the challenges and find out amicable solution before making investment decision.
“Russian Pharma Sector Forecast to 2013” provides an extensive research, rational analysis and reliable statistics of the Russian pharma sector to present a clear picture of the country’s healthcare and pharmaceutical market. It covers leading drugs, segment-wise break up, and information about major therapy areas to give strategic insight into the market. The report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast in this research has been made considering the possible impact of post-recession on the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM243.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Besides high prices of drugs, the Russian pharmaceutical industry will benefit from the dynamic government support and increasing private investments. Several other factors such as growing healthcare spending and obligatory and voluntary insurance schemes have boosted the intake of high-priced drugs in the country. Infectious diseases like HIV/AIDS are on the rise and Russia is transforming into a more conducive environment for clinical trials, which will further pave the way for the growth of pharmaceutical industry in the country.
Our research indicates that the Russian pharmaceutical market has immense growth potential and is in the initial stages of development. The country is highly dependent on imported drugs, giving room to private players to set up their own manufacturing capacities. This will boost the commercial drugs segment to occupy the largest market share by 2013.
Although the future prospects of commercial drugs segment seem optimistic and encouraging, there are still several factors that may restraint the growth of pharmaceutical market in Russia. Our research report throws light on these restraints to help clients comprehend the challenges and find out amicable solution before making investment decision.
“Russian Pharma Sector Forecast to 2013” provides an extensive research, rational analysis and reliable statistics of the Russian pharma sector to present a clear picture of the country’s healthcare and pharmaceutical market. It covers leading drugs, segment-wise break up, and information about major therapy areas to give strategic insight into the market. The report has thoroughly examined current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast in this research has been made considering the possible impact of post-recession on the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM243.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




